Flower, M., Lomeikaite, V., Ciosi, M., Cumming, S., Morales Montero, F., Lo, K., . . . Tabrizi, S. J. (2019). MSH3 modifies somatic instability and disease severity in Huntington’s and myotonic dystrophy type 1.
Chicago ZitierstilFlower, Michael, et al. MSH3 Modifies Somatic Instability and Disease Severity in Huntington’s and Myotonic Dystrophy Type 1. 2019.
MLA ZitierstilFlower, Michael, et al. MSH3 Modifies Somatic Instability and Disease Severity in Huntington’s and Myotonic Dystrophy Type 1. 2019.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.